Back
Frontier Communications Parent Vs. Kymera Therapeutics Industry Stock Comparison
Buy
57
FYBR
Frontier Communications Parent
Last Price:
$36.19
Seasonality Move:
14.15%
Buy
77
KYMR
Kymera Therapeutics
Last Price:
$45.92
Seasonality Move:
30.84%
Buy
57
Frontier Communications Parent (FYBR)
is a Buy
Is Frontier Communications Parent a Buy, Sell or Hold?
-
The current Frontier Communications Parent [FYBR] share price is $36.18. The Score for FYBR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
FYBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $45.87. The Score for KYMR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FYBR Stock Price Chart
What is Frontier Communications Parent's stock price today?
-
The Frontier Communications Parent share price today is $36.18Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FYBR is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $45.87The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
FYBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 42.63 | Sell |
Chaikin Money Flow: | -2288417 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.18 - 36.62) | Sell |
Bollinger Bands (100): | (35.75 - 36.39) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.05 | Buy |
Relative Strength Index (14 RSI): | 67.57 | Buy |
Chaikin Money Flow: | 251231 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.82 - 47.48) | Buy |
Bollinger Bands (100): | (27.31 - 40.79) | Buy |
FYBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.19 | Sell |
20-day SMA: | 36.33 | Sell |
50-day SMA: | 36.32 | Sell |
200-day SMA: | 35.53 | Buy |
8-day EMA: | 36.21 | Sell |
20-day EMA: | 36.29 | Sell |
50-day EMA: | 36.25 | Sell |
200-day EMA: | 34.34 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.09 | Sell |
20-day SMA: | 41.33 | Buy |
50-day SMA: | 34.42 | Buy |
200-day SMA: | 39.62 | Buy |
8-day EMA: | 46.1 | Sell |
20-day EMA: | 42.54 | Buy |
50-day EMA: | 37.49 | Buy |
200-day EMA: | 36.91 | Buy |
Frontier Communications Parent Earnings Growth & FYBR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.21 per share, and a decrease next year of $0.01 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.40 per share.
Frontier Communications Parent Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |